Jan 22 (Reuters) - Nabi Biopharmaceuticals (NABI.O) said its board authorized the exploration of strategic options, which will focus on a sale or merger of the company. The drugmaker has engaged Banc of America Securities LLC as financial advisor for the strategic alternatives process. (Reporting by Sreerupa Mitra in Bangalore; Editing by Pratish Narayanan)
SEATTLE (Reuters) - Microsoft Corp said on Tuesday it will tweak its Word application to remove a feature judged to be a breach of patent, ensuring that it will be able to continue selling one of its most widely used programs.
Data security breaches are nasty business and should be avoided at all costs, writes Kevin Prince, a chief technology officer at Perimeter e-Security. Here's a look at the biggest breaches and blunders of 2009. Commentary
There are some 115,000 U.S. troops in Iraq -- and one commander wants to make sure his soldiers don't multiply. Full Article
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
